UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034963
Receipt number R000039866
Scientific Title A randomized, double-blind, placebo-controlled parallel-group superiority study on the skin function index of ingredient obtained from plant in healthy adult females
Date of disclosure of the study information 2018/11/23
Last modified on 2019/12/23 11:26:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized, double-blind, placebo-controlled parallel-group superiority study on the skin function index of ingredient obtained from plant in healthy adult females

Acronym

A randomized, double-blind, placebo-controlled parallel-group superiority study on the skin function index of ingredient obtained from plant in healthy adult females

Scientific Title

A randomized, double-blind, placebo-controlled parallel-group superiority study on the skin function index of ingredient obtained from plant in healthy adult females

Scientific Title:Acronym

A randomized, double-blind, placebo-controlled parallel-group superiority study on the skin function index of ingredient obtained from plant in healthy adult females

Region

Japan


Condition

Condition

Healthy people

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to evaluate efficacy of food containing ingredient obtained from plant for skin function of healthy females.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Index for skin conditions (Skin moisuture content, Transepidermal water loss, Skin viscoelasticity)

Key secondary outcomes

Observation for skin condition
Collagen Score (measuring with ultrasonic waves)
Subjective symptoms for skin condition (VAS)
POMS


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Intake of the test food (2 capsules/day, 12 weeks)

Interventions/Control_2

Intake of control food (2 capsules/day, 12 weeks)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

55 years-old >

Gender

Female

Key inclusion criteria

Japanese adult female aged from 30 to 54 years old at time of informed consent was provided

Key exclusion criteria

1) Individuals who use regularly cosmetology or food affecting the skin condition
2) Individuals who have skin disease, or whose skin have an abnormality requiring treatment, or who have disease with affecting skin condition
3) Individuals who need to wear masks or to blow their nose due to allergic rhinitis or individuals who maybe develop the allergy during the study
4) Individuals who have chronic disease
5) Individuals with serious disorders or individuals with histories of serious disorders
6) Individuals who excessively take alcohol
7) Individuals who is smoker (smoking over 20 cigarettes/day)
8) Individuals who have a history of serious drug allergy or serious food allergy
9) Individuals who are pregnant or Individuals who are willing to become pregnant or lactation during this study
10) Individuals who are participating in other clinical trials or individuals who participated in other clinical trials within 1 month
11) Any Individuals considered to be unsuitable for enrollment in the opinion of the principal investigator

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Mamoru
Middle name
Last name Hanyuuda

Organization

Breast Health Clinic

Division name

Breast Health Clinic

Zip code

103-0025

Address

3-8-10 Nihonbashi Kayabacho, Chuo-ku, Tokyo, Japan

TEL

03-6667-0345

Email

imai@kt-medical.co.jp


Public contact

Name of contact person

1st name Shigeru
Middle name
Last name Imai

Organization

KT Medical Corporation

Division name

Food clinical trial division

Zip code

100-0005

Address

6F 2-2-3 Marunouchi,Chiyoda-ku, Tokyo, Japan

TEL

03-6667-0345

Homepage URL


Email

imai@kt-medical.co.jp


Sponsor or person

Institute

KT Medical Corporation

Institute

Department

Personal name



Funding Source

Organization

Morinaga Milk Industry Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Department of Dermatology,
Wakayama Medical University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Japan Conference of Clinical Research

Address

2-27-17 Minamiikebukuro Toshima-ku, Tokyo, Japan

Tel

03-6868-7022

Email

jccr-info@cts-smo.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

ブレストヘルスクリニック(東京都)


Other administrative information

Date of disclosure of the study information

2018 Year 11 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 11 Month 22 Day

Date of IRB

2018 Year 11 Month 22 Day

Anticipated trial start date

2018 Year 12 Month 16 Day

Last follow-up date

2019 Year 03 Month 25 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 11 Month 21 Day

Last modified on

2019 Year 12 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039866


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name